We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
8 hedge funds and large institutions have $86.2K invested in ZyVersa Therapeutics in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,094% more capital invested
Capital invested by funds: $7.22K → $86.2K (+$79K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more funds holding
Funds holding: 6 → 8 (+2)
2.94% more ownership
Funds ownership: 0.29% → 3.23% (+2.9%)
Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citigroup
New York
|
+$55.3K |
| 2 |
VF
Virtu Financial
New York
|
+$39.9K |
| 3 |
Renaissance Technologies
New York
|
+$20.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.92K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.45K |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citigroup
New York
| $37.1K | +$55.3K | +35,035 | New |
|
|
VF
2
Virtu Financial
New York
| $27K | +$39.9K | +25,259 | New |
|
|
3
Renaissance Technologies
New York
| $13.7K | +$20.5K | +12,961 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $4.44K | +$5.92K | +3,754 | +867% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.69K | +$1.45K | +917 | +36% |
|
6
Bank of America
Charlotte,
North Carolina
| $115 | +$159 | +101 | +1,263% |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $53 | +$79 | +50 | New |
|
8
Morgan Stanley
New York
| $1 | – | – | – |
|
|
9
JP Morgan Chase
New York
| – | -$2 | -1 | Closed |
|